PRIMARY SCLEROSING CHOLANGITIS (PSC)
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS (PSC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS (PSC) trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Poop pills could tame rare liver disease
Disease control Not yet recruitingThis study tests whether fecal microbiota transplantation (FMT) can improve liver function in people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). 72 participants will receive either FMT or a sham procedure via colonoscopy and later oral capsules…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Old antibiotic, new hope? vancomycin trial for UC and PSC
Disease control Not yet recruitingThis pilot study tests whether the antibiotic vancomycin can safely treat active ulcerative colitis in adults who also have primary sclerosing cholangitis, a liver condition. Fourteen participants will take vancomycin or a placebo for 4 weeks, with an optional 4-week extension. T…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC